| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/02/2003 | EP1267956A2 Injectable microspheres for dermal augmentation and tissue bulking |
| 01/02/2003 | EP1267947A1 Microcapsules comprising functionalised polyalkylcyanoacrylates |
| 01/02/2003 | EP1267946A2 Nanocapsule encapsulation system and method |
| 01/02/2003 | EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267716A1 Method of magnetic resonance imaging |
| 01/02/2003 | EP1267715A1 Method of magnetic resonance imaging |
| 01/02/2003 | EP1015419B1 Polydentate imines and their metal complexes |
| 01/02/2003 | EP0910414B1 A diagnostic test for schizophrenia, using niacin |
| 01/02/2003 | EP0831928B1 Magnetic resonance imaging agents for the detection of physiological agents |
| 01/02/2003 | EP0489119B2 Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| 12/31/2002 | US6500918 Conjugate comprising an antinociceptive agent covalently bonded to a blood component |
| 12/31/2002 | US6500341 Process for the purification of water-soluble non-ionic contrast agents |
| 12/27/2002 | WO2002103351A1 Method of detecting skin stimulation effect |
| 12/27/2002 | WO2002103038A1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase |
| 12/27/2002 | WO2002102825A2 Fluorescently labelled locked nucleic acids |
| 12/27/2002 | WO2002102386A1 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 12/27/2002 | WO2002102251A1 Improved method of measuring changes in microvascular capillary blood flow |
| 12/27/2002 | WO2002102239A2 Method of early detection of duchenne muscular dystrophy and other neuromuscular disease |
| 12/27/2002 | WO2002020610A3 Conformationally constrained labeled peptides for imaging and therapy |
| 12/27/2002 | WO2002012467A3 Drug metabolizing enzymes |
| 12/27/2002 | WO2001094587A3 Extracellular messengers |
| 12/27/2002 | CA2450847A1 Novel compositions |
| 12/26/2002 | US20020197648 High throughput screening methods using magnetic resonance imaging agents |
| 12/26/2002 | US20020197604 Extraction of preferential polypeptide from skin; obtain skin, remove preferential layer, extract preferential protein |
| 12/26/2002 | US20020197306 Cationic lipid compositions targeting angiogenic endothelial cells |
| 12/26/2002 | US20020197211 Administration of dispersions by infusion |
| 12/26/2002 | US20020197209 Diagnostic imaging of lymph structures |
| 12/26/2002 | US20020196893 CT scanner for and method of imaging a preselected portion of the lower abdomen region of a patient |
| 12/26/2002 | US20020196116 Hyperpolarized gas containers, solenoids, transport and storage devices and associated transport and storage methods |
| 12/24/2002 | US6498945 Free radical generation of water soluble polymer to enhance cytopathogenic efficacy |
| 12/24/2002 | US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis |
| 12/24/2002 | CA2147863C Determination of peptide motifs on mhc molecules |
| 12/19/2002 | WO2002101043A2 Regulation of human ta4 receptor |
| 12/19/2002 | WO2002101009A2 Structural and cytoskeleton-associated proteins |
| 12/19/2002 | WO2002101008A2 Intracellular signaling molecules |
| 12/19/2002 | WO2002100444A1 Colloidal metal labelled microparticles, their production and use |
| 12/19/2002 | WO2002100443A2 Identifying tissue within the body using a fluorescent dye |
| 12/19/2002 | WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 12/19/2002 | WO2002100353A2 Cd10-activated prodrug compounds |
| 12/19/2002 | WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 12/19/2002 | WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 12/19/2002 | WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 12/19/2002 | WO2002070678A3 Regulation of human serine/threonine protein kinase |
| 12/19/2002 | WO2002053093A3 Regulation of eating habits |
| 12/19/2002 | WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof |
| 12/19/2002 | WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 12/19/2002 | WO2001068679A9 Peptides targeting specifically tumor-derived endothelial cells |
| 12/19/2002 | US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 12/19/2002 | US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody |
| 12/19/2002 | US20020193850 Use of photodynamic therapy to treat prostatic tissue |
| 12/19/2002 | US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody |
| 12/19/2002 | US20020193442 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 12/19/2002 | US20020193295 Immunogenic peptides and uses thereof |
| 12/19/2002 | US20020192826 Recombinant AAV vector-based transduction system and use of same |
| 12/19/2002 | US20020192821 Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease |
| 12/19/2002 | US20020192730 Monitoring therapies for vision defects, psoriasis, cancer, rheumatoid arthritis, atherosclerosis and kaposi's sarcoma; obtain cells, incubate with antiproliferative agents, monitor concentration of progenitor cells, compare to control |
| 12/19/2002 | US20020192688 Imaging nucleic acid delivery |
| 12/19/2002 | US20020192683 Fluorescent cobalamins and uses thereof |
| 12/19/2002 | US20020192223 Novel antibody conjugates reactive with human carcinomas |
| 12/19/2002 | US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 12/19/2002 | US20020192161 Animal model for evaluating analgesics |
| 12/19/2002 | US20020192159 Single-patient drug trials used with accumulated database: flowchart |
| 12/19/2002 | US20020192157 Treatment and diagnosis of macrophage mediated disease |
| 12/19/2002 | CA2450316A1 Cd10-activated prodrug compounds |
| 12/19/2002 | CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 12/19/2002 | CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 12/19/2002 | CA2449440A1 Structural and cytoskeleton-associated proteins |
| 12/19/2002 | CA2449272A1 Intracellular signaling molecules |
| 12/18/2002 | EP1266012A2 Proteases |
| 12/18/2002 | EP1265942A2 Use of poly(diallylamine) polymers |
| 12/18/2002 | EP1265640A1 Fluorescent membrane intercalating probes and methods for their use |
| 12/18/2002 | EP1265546A1 Methods and apparatus for optical imaging |
| 12/18/2002 | EP1265527A2 Diagnostic procedures using direct injection of gaseous hyperpolarized ?129 xe and associated systems and products |
| 12/18/2002 | EP0994729B1 Use of intravenous contrast agents and devices for projection mammography |
| 12/18/2002 | EP0989847B1 Anti-tumoral therapy agent |
| 12/18/2002 | EP0917474B1 Pseudopolyrotaxanes |
| 12/18/2002 | EP0814848B1 Microparticles, agents containing said microparticles for use in ultrasound diagnostics, and processes for producing said particles and agents |
| 12/17/2002 | US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 12/17/2002 | US6495585 Method for treating hyperproliferative tissue in a mammal |
| 12/17/2002 | US6495527 Enhancing binding ability of a protein, such as human serum albumin; therapeutic agent carrier |
| 12/17/2002 | US6495118 Lipophilic metal complexes for necrosis and infarction imaging |
| 12/17/2002 | US6494859 Methods using pressure to obtain fluids and cellular material from breast ducts |
| 12/17/2002 | CA2085464C Using 5,10,15,10-tetrakis (r-carboxyphenyl)porphine for detecting and treating lung cancer |
| 12/17/2002 | CA1341411C Method for producing fv fragments in eukaryotic cells |
| 12/13/2002 | CA2369717A1 Method for evaluating drug sensitivity |
| 12/12/2002 | WO2002099422A2 Individualization of therapy with alzheimer's disease agents |
| 12/12/2002 | WO2002099418A1 Premalignant, serially-transplantable breast tissue lines and uses thereof |
| 12/12/2002 | WO2002099123A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder |
| 12/12/2002 | WO2002098469A1 In vivo assay for anti angiogenic compounds |
| 12/12/2002 | WO2002098216A1 Animal model for allergy |
| 12/12/2002 | WO2002068930A3 Methods and reagents to acquire mri signals and images |
| 12/12/2002 | WO2002034297A3 Endoscopic vascular visualisation, diagnostic and/or surgical procedure |
| 12/12/2002 | US20020188281 Stabilized bioactive preparations and method of use |
| 12/12/2002 | US20020188202 Method of diagnosis and treatment and related compositions and apparatus |
| 12/12/2002 | US20020188196 Cavity-filling biopsy site markers |
| 12/12/2002 | US20020188111 For photodynamic therapy of a lesion; medical diagnosis; drug screening; bioavailability |
| 12/12/2002 | US20020187499 Kit for use in monitoring and treatment of endometriosis |
| 12/12/2002 | US20020187172 Polymeric material associated with colloidal metal particles, especially gold, suitable for injection or implantation. |
| 12/12/2002 | US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |